TNF and rheumatoid arthritis: Another study indicated that exosomes derived from BMSCs have the ability to hinder the release of IL-1β, tumor necrosis factor-α (TNF-α), and IL-18, as well as the activation of NLRP3 in macrophages and RA rats.